Content about Walgreens Specialty Pharmacy

February 28, 2012

Walgreens Specialty Pharmacy in late February released data showing that both patients and their health plans can realize savings of up to 60% on the cost of infused specialty medications by choosing alternate treatment sites, such as the ones fielded by Walgreens. DSN caught up with Michael Einodshofer, director of utilization management at Walgreens Specialty Pharmacy, to discuss the potential cost-reduction impact savings it can have on employers and payers.

AUDIO Q&A: Walgreens Specialty Pharmacy in late February released data showing that both patients and their health plans can realize savings of up to 60% on the cost of infused specialty medications by choosing alternate treatment sites, such as the ones fielded by Walgreens.

February 11, 2014

The Pharmacy Benefit Management Institute recently released its Specialty Drug Benefit Report, sponsored by Walgreens Specialty Pharmacy.

PLANO, Texas — The Pharmacy Benefit Management Institute recently released its Specialty Drug Benefit Report, sponsored by Walgreens Specialty Pharmacy. The 2014 edition highlights trends important to specialty pharmacy, including emerging cost-control strategies and challenges affecting benefit design and patient care. 

January 9, 2014

Administering high-touch, expensive and complex medications to patients intravenously in their homes — or in a setting other than a hospital — is essentially a large-scale bid to “reduce costs by transferring non-self-administered drugs to the most cost-effective and clinically appropriate site of care,” said pharmacist Michael Einodshofer, senior director of specialty strategy and innovation at Walgreens Specialty Pharmacy.

Administering high-touch, expensive and complex medications to patients intravenously in their homes — or in a setting other than a hospital — is essentially a large-scale bid to “reduce costs by transferring non-self-administered drugs to the most cost-effective and clinically appropriate site of care,” said pharmacist Michael Einodshofer, senior director of specialty strategy and innovation at Walgreens Specialty Pharmacy.

May 21, 2013

More evidence is emerging that interventions by pharmacists can have a profound beneficial effect on patient outcomes.

The latest example comes from Walgreens Specialty Pharmacy, which released the results of a study May 17 showing that more than two-thirds of patients with hepatitis C “achieved sustained virologic response or cure after completing newer ‘triple therapy’ treatment” backed up by a regimen of care and oversight by pharmacists, according to a Drug Store News report from senior editor Michael Johnsen.

Why the pharmacist interventions? They help improve patient compliance with the complicated drug therapy, which involves the administration of two newer protease inhibitors to prevent the HCV virus from reproducing, in combination with peginterferon and ribavirin. According to Johnsen, that powerful medicinal cocktail “significantly increased the cure rate and cut treatment time in half” for the 406 HCV patients in the study who received triple therapy with either telaprevir or boceprevir.

More evidence is emerging that interventions by pharmacists can have a profound beneficial effect on patient outcomes.

February 19, 2013

Management of specialty drugs under the medical benefit continues to trail management under the pharmacy benefit, according to a new report by the Pharmacy Benefit Management Institute.

PLANO, Texas — Management of specialty drugs under the medical benefit continues to trail management under the pharmacy benefit, according to a new report by the Pharmacy Benefit Management Institute.

May 3, 2012

Walgreens Specialty Pharmacy on Thursday added six medications to its oral oncology cycle management program, in a significant expansion of the comprehensive treatment and support program it provides to benefit patients, physicians and payers, the company announced.

DEERFIELD, Ill. — Walgreens Specialty Pharmacy on Thursday added six medications to its oral oncology cycle management program, in a significant expansion of the comprehensive treatment and support program it provides to benefit patients, physicians and payers, the company announced.

February 24, 2012

"I appreciate the fact that [Walgreens is] trying to do some very good things with respect to clinical offerings and other avenues to try to impact the overall healthcare spectrum. But quite frankly, that hasn't been proven to reduce cost."

WHAT IT MEANS AND WHY IT'S IMPORTANT — "I appreciate the fact that [Walgreens is] trying to do some very good things with respect to clinical offerings and other avenues to try to impact the overall healthcare spectrum. But quite frankly, that hasn't been proven to reduce cost." That was what George Paz, Express Scripts chairman, president and CEO, said Thursday morning about the go-to-market strategy currently being employed by Walgreens. Later that day, Walgreens released these data — contrary to Paz's take on the value of Walgreens.

February 24, 2012

Walgreens Specialty Pharmacy on Thursday released data showing that both patients and their health plans can realize savings of up to 60% on the cost of infused specialty medications by choosing alternate treatment sites.

DEERFIELD, Ill. — Walgreens Specialty Pharmacy on Thursday released data showing that both patients and their health plans can realize savings of up to 60% on the cost of infused specialty medications by choosing alternate treatment sites. The cost savings was the key finding from new data being presented at the 2012 Pharmacy Benefit Management Institute Annual Drug Benefit Conference in Scottsdale, Ariz.


August 24, 2011

Specialty pharmacy is expanding beyond its traditional base as a central-fill and mail-order distribution model for patients. A new, community-driven model is emerging, led by a fast-growing network of integrated, 
community-based specialty providers based in Drexel Hill, Pa.

Specialty pharmacy is expanding beyond its traditional base as a central-fill and mail-order distribution model for patients. A new, community-driven model is emerging, led by a fast-growing network of integrated, 
community-based specialty providers based in Drexel Hill, Pa.

November 30, 2010

Leaders in specialty pharmacy gathered in New York on Tuesday at the New York Athletic Club to attend the second annual Specialty Pharmacy Roundtable discussion presented by Drug Store News and Armada Health Care.

NEW YORK — Leaders in specialty pharmacy gathered in New York on Tuesday at the New York Athletic Club to attend the second annual Specialty Pharmacy Roundtable discussion presented by Drug Store News and Armada Health Care.

David Galardi, co-founder of Apogenics Inc., moderated the robust panel, which was comprised of Nick Calla of Walgreens Specialty Pharmacy, John Musil of The Apothecary Shops, Tim Kaplan of Amber Pharmacy, Jeanne Ann Stasny of Walmart Specialty Pharmacy and Albert Thigpen of CVS Caremark, among others.

November 21, 2010

An intensive cancer patient management program by Walgreens’ specialty pharmacy professionals could save health plan...

DEERFIELD, Ill. An intensive cancer patient management program by Walgreens’ specialty pharmacy professionals could save health plan payers $2,000 to $4,000 per patient each month, the company announced.